Does Augmentin Work on Bronchitis?
No, Augmentin (amoxicillin-clavulanate) should NOT be routinely used for acute bronchitis in immunocompetent adults, as antibiotics provide minimal to no benefit for this typically viral, self-limiting condition. 1, 2
When Antibiotics Are NOT Indicated
For uncomplicated acute bronchitis in immunocompetent adults:
- Do not prescribe antibiotics routinely 1
- Acute bronchitis is typically viral and self-limiting
- The 2020 CHEST guidelines explicitly recommend against routine antibiotic therapy 1
- A Cochrane review of 17 trials (3,936 participants) found antibiotics provided only marginal benefits: patients had slightly shorter cough duration (0.46 days less) but experienced more adverse effects (1 in 5 patients had side effects) 3
The Critical Exception: COPD Exacerbations
Augmentin IS appropriate for COPD exacerbations with bacterial features, limited to 5 days of treatment 2
Prescribe antibiotics when all three of these bacterial infection criteria are present:
- Increased sputum purulence (most important)
- Increased dyspnea
- Increased sputum volume
For COPD exacerbations meeting these criteria, use 5 days of treatment targeting Haemophilus influenzae, Streptococcus pneumoniae, and Moraxella catarrhalis 2. Augmentin covers these pathogens, including β-lactamase-producing strains 4, 5.
When to Reassess
If acute bronchitis worsens or persists despite initial management:
- Reassess the patient for alternative diagnoses 1
- Consider:
- Bacterial pneumonia (requires chest X-ray)
- COPD exacerbation
- Asthma exacerbation
- Bacterial sinusitis
- Bronchiectasis
- Only prescribe antibiotics if a complicating bacterial infection is likely 1
Common Pitfalls to Avoid
- Don't prescribe antibiotics just because sputum is colored - this alone doesn't indicate bacterial infection in acute bronchitis
- Don't extend treatment beyond 5 days for COPD exacerbations - longer courses show no additional benefit 2
- Don't use Augmentin for chronic bronchitis exacerbations without COPD - the evidence supports its use specifically in COPD patients with bacterial features 6
- Be aware of side effects - Augmentin causes diarrhea in 22-37% of patients, significantly more than other antibiotics 7, 8
FDA-Approved Indications
The FDA label for Augmentin does not list acute bronchitis as an approved indication 9. The approved respiratory indications are limited to:
- Recurrent/persistent acute otitis media in children
- Acute bacterial sinusitis (in specific formulations)
- Community-acquired pneumonia (not bronchitis)
Bottom Line Algorithm
- Acute bronchitis in healthy adults → No antibiotics
- Acute bronchitis worsening → Reassess for pneumonia or other diagnoses
- COPD patient with purulent sputum + increased dyspnea + increased sputum volume → Augmentin for 5 days 2
- Any other scenario → Antibiotics not indicated unless alternative bacterial diagnosis confirmed